Aggressive · Stocks to Consider and Updates

CSX Beats Earnings Estimates; Revenue Disappoints

Jacksonville, Florida’s CSX Corp. (NASDAQ: CSX - $57.77) announced fourth quarter 2017 adjusted earnings of $573 million or $0.64 per share vs. Street estimates of $0.56/share and last year’s $0.49. Revenue for the period, however, decreased 6% compared to the previous year, to $2.86 billion primarily due to the $178 million impact of an extra fiscal week in 2016… Continue reading CSX Beats Earnings Estimates; Revenue Disappoints

Aggressive · Stocks to Consider and Updates

Chase Beats Earnings Estimates; Guidance Improves

JPMorgan Chase & Co. (NYSE: JPM - $111.27) recorded adjusted earnings for the fourth quarter of $1.76 a share compared to $1.71 in the year-earlier period and seven cents better than analysts’ estimates.  For all of 2017, reported results came in at $6.98 per share, compared to 2016’s $6.19. Revenues rose 5% in the fourth… Continue reading Chase Beats Earnings Estimates; Guidance Improves

Aggressive · Stocks to Consider and Updates

Delta Air Posts Strong Results

Atlanta-based Delta Air Lines (NYSE: DAL - $57.70) profit and sales beat expectations with net income for the quarter of $572 million. Excluding non-recurring items, adjusted earnings per share came to $0.96, above the Street consensus of $0.88 and last year's $0.32. Total operating revenue rose 8.3% to $10.25 billion, also beating estimates of $10.13 billion, amid a 7%… Continue reading Delta Air Posts Strong Results

Aggressive · Stocks to Consider and Updates

CSX Shares Fall on Harrison Medical News

Shares of rail and intermodal carrier CSX Corp. (NASDAQ: CSX - $52.62) are tumbling about 8% in today’s trading after the company announced that legendary CEO E. Hunter Harrison was on medical leave due to unexpected complications from a recent illness. Consequently, the board of directors has named COO James M. Foote as acting CEO.… Continue reading CSX Shares Fall on Harrison Medical News

Aggressive · Stocks to Consider and Updates

Jabil Circuit Posts Solid Earnings; Confirms Guidance

Electronics solutions provider Jabil Circuit, Inc. (NYSE: JBL - $27.86) reported fiscal first quarter earnings and revenue that topped analysts' expectations; it also provided guidance for the second period, in line with Street views. For the quarter ended Nov. 30, Jabil posted adjusted earnings of $0.80 per share, compared with the prior-year period's $0.69 and two cents above analysts’ views.… Continue reading Jabil Circuit Posts Solid Earnings; Confirms Guidance

Aggressive · Stocks to Consider and Updates

Gilead Sciences to Acquire Cell Design Labs

Gilead Sciences, Inc. (NASDAQ: GILD - $73.57) and its cell therapy subsidiary Kite, announced that they have they have agreed to acquire privately held Cell Design Labs, Inc., gaining new technology platforms that will enhance research and development efforts in cellular therapy. Under the terms of the agreement, Gilead will acquire all the outstanding shares of Cell Design… Continue reading Gilead Sciences to Acquire Cell Design Labs

Aggressive · Stocks to Consider and Updates

The iShares Emerging Markets Fund – Update

The iShares Emerging Markets ETF (NYSE: EEM - $46.93) tracks the market-cap-weighted MSCI Emerging Markets Index, which includes over 800 large-and mid-cap stocks across 24 non-developed markets. The fund generally invests at least 90% of its assets in the securities and depository receipts of its underlying index. It effectively diversifies firm-specific risk, promotes low turnover and… Continue reading The iShares Emerging Markets Fund – Update